ERC -- Table of Contents (Autumn 1996, 3 [3])

TABLE OF CONTENTS

QUICK SEARCH:

	Author:		Keyword(s):
Year:		Vol:		Page:

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Autumn 1996, Volume 3, Issue 3 [Index by Author] Other Issues:

Articles

Find articles in this issue containing these words:
[Search ALL Issues]

Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Fernand Labrie: Editorial; Endocr Relat Cancer 1996 3: 145-146. [Abstract] [PDF]

J Hugosson and G Aus: Natural evolution of prostate cancer; Endocr Relat Cancer 1996 3: 147-155. [Abstract] [PDF]

P J Chuba, A T Porter, E Ben-Josef, K Hart, and J D Forman: Curative treatment of prostate cancer with the combination of radiation and hormone therapies; Endocr Relat Cancer 1996 3: 157-163. [Abstract] [PDF]

B Têtu: Morphologic changes induced by neoadjuvant combination hormone therapy on prostatic tissue and prostate cancer; Endocr Relat Cancer 1996 3: 165-170. [Abstract] [PDF]

F Lee, D B Siders, T A McHugh, M H Solomon, and D M Mayman: Neoadjuvant androgen ablation therapy prior to radical prostatectomy: results of a 3-year follow-up; Endocr Relat Cancer 1996 3: 171-177. [Abstract] [PDF]

P H Gann: Prostate-specific antigen screening for prostate cancer: issues involving test validity; Endocr Relat Cancer 1996 3: 179-189. [Abstract] [PDF]

J Leinonen and U-H Stenman: Significance of free and bound prostate-specific antigen; Endocr Relat Cancer 1996 3: 191-197. [Abstract] [PDF]

P J Littrup: Economics of prostate cancer screening: racial implications; Endocr Relat Cancer 1996 3: 199-203. [Abstract] [PDF]

C C Schulman: Controversial aspects of neoadjuvant hormonal deprivation prior to radical prostatectomy; Endocr Relat Cancer 1996 3: 205-209. [Abstract] [PDF]

P Limonta, R M Moretti, M Montagnani Marelli, D Dondi, and M Motta: LHRH as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action; Endocr Relat Cancer 1996 3: 211-216. [Abstract] [PDF]

C Chen, X Li, S Singh, A Bélanger, and F Labrie: Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma; Endocr Relat Cancer 1996 3: 217-227. [Abstract] [PDF]

S Luo, C Martel, G LeBlanc, B Candas, S M Singh, C Labrie, J Simard, A Bélanger, and F Labrie: Relative potencies of Flutamide and Casodex: preclinical studies; Endocr Relat Cancer 1996 3: 229-241. [Abstract] [PDF]

F Labrie, A Bélanger, L Cusan, C Labrie, J Simard, V Luu-The, P Diamond, J-L Gomez, and B Candas: History of LHRH agonist and combination therapy in prostate cancer; Endocr Relat Cancer 1996 3: 243-278. [Abstract] [PDF]

S Waxman and E D Crawford: Endocrine therapy of advanced carcinoma of the prostate; Endocr Relat Cancer 1996 3: 279-283. [Abstract] [PDF]

R A Janknegt and T A Boon: Primary hormo-chemotherapy in metastatic prostate cancer; Endocr Relat Cancer 1996 3: 285-292. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

TABLE OF CONTENTS

Copyright © 2008 by the Society for Endocrinology.